HHS Scores Early Win In Boehringer's Medicare Pricing Suit
By Hailey Konnath · July 3, 2024, 11:30 PM EDT
A Connecticut federal judge on Wednesday sided with the U.S. Department of Health and Human Services in Boehringer Ingelheim's challenge to a new Medicare drug price negotiation program, rejecting the pharmaceutical...
To view the full article, register now.